ECSP22045408A - Bacterias productoras de serotonina - Google Patents
Bacterias productoras de serotoninaInfo
- Publication number
- ECSP22045408A ECSP22045408A ECSENADI202245408A ECDI202245408A ECSP22045408A EC SP22045408 A ECSP22045408 A EC SP22045408A EC SENADI202245408 A ECSENADI202245408 A EC SENADI202245408A EC DI202245408 A ECDI202245408 A EC DI202245408A EC SP22045408 A ECSP22045408 A EC SP22045408A
- Authority
- EC
- Ecuador
- Prior art keywords
- serotonin
- culture medium
- lactic acid
- bacterial strain
- deficiency
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
Abstract
La invenci?n se relaciona con la selecci?n de cepas bacterianas para su uso en el tratamiento de la deficiencia de serotonina y/o de una enfermedad relacionada con la deficiencia de serotonina mediante el cultivo de bacterias de una cepa bacteriana productora de ?cido l?ctico, en condiciones aer?bicas, en un medio de cultivo que comprende tript?fano. Cualquier serotonina producida por las bacterias de la cepa bacteriana productora de ?cido l?ctico en el medio de cultivo se detecta y la cepa bacteriana productora de ?cido l?ctico se selecciona como aquella efectiva en el tratamiento de la deficiencia de serotonina y/o de una enfermedad relacionada con la deficiencia de serotonina en un sujeto si se detecta serotonina en el medio de cultivo
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1951292 | 2019-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP22045408A true ECSP22045408A (es) | 2022-07-29 |
Family
ID=73449153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSENADI202245408A ECSP22045408A (es) | 2019-11-08 | 2022-06-07 | Bacterias productoras de serotonina |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US12295975B2 (es) |
| EP (2) | EP4253571A3 (es) |
| JP (1) | JP7649782B2 (es) |
| KR (1) | KR102707788B1 (es) |
| CN (1) | CN114729299B (es) |
| AU (1) | AU2020379517B2 (es) |
| BR (1) | BR112022008559A2 (es) |
| CA (1) | CA3159798A1 (es) |
| CL (1) | CL2022001042A1 (es) |
| CO (1) | CO2022005107A2 (es) |
| EC (1) | ECSP22045408A (es) |
| ES (1) | ES2961551T3 (es) |
| HR (1) | HRP20231084T1 (es) |
| HU (1) | HUE063707T2 (es) |
| IL (1) | IL292709B2 (es) |
| MX (1) | MX2022005064A (es) |
| MY (1) | MY208563A (es) |
| PH (1) | PH12022551075A1 (es) |
| PL (1) | PL3897836T3 (es) |
| WO (1) | WO2021091474A1 (es) |
| ZA (1) | ZA202204539B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019216129B2 (en) * | 2018-02-02 | 2022-03-17 | Kobiolabs, Inc. | Lactobacillus plantarum KBL396 strain and use thereof |
| CN117187342B (zh) * | 2022-09-27 | 2024-07-26 | 合肥瀚微生物科技有限公司 | 一种基于质谱检测肠道内单个细菌代谢物的方法 |
| CN117143767B (zh) * | 2023-08-23 | 2024-06-11 | 浙江民生健康科技有限公司 | 可调节肠道菌群的母乳源发酵粘液乳杆菌msjk0025及其应用 |
| WO2026003337A1 (en) * | 2024-06-27 | 2026-01-02 | Chr. Hansen A/S | Selection of lactic acid bacteria for storage at ambient temperatures |
| CN118853480B (zh) * | 2024-07-30 | 2026-01-09 | 江南大学 | 一株显著提高5-ht4r修复肠神经的两歧双歧杆菌及其应用 |
| CN118792218A (zh) * | 2024-08-20 | 2024-10-18 | 广西爱生生命科技有限公司 | 一种具有抗炎和分泌5-ht功能的戊糖片球菌菌株a20001及其衍生产品和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2826808B2 (ja) * | 1995-07-14 | 1998-11-18 | カルピス株式会社 | 脳機能改善、学習能力増強および記憶力増強作用を有する機能性食品 |
| JP3467377B2 (ja) * | 1997-04-22 | 2003-11-17 | 典子 金城 | メラトニンの製造方法 |
| KR100437497B1 (ko) * | 2001-03-07 | 2004-06-25 | 주식회사 프로바이오닉 | 로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제 |
| US7344867B2 (en) | 2005-04-15 | 2008-03-18 | Eamonn Connolly | Selection and use of lactic acid bacteria for reducing inflammation in mammals |
| US8603460B2 (en) * | 2006-06-05 | 2013-12-10 | Brogaia AB | Method of making a Lactobacillus reuteri with increased acid tolerance |
| FI126711B (fi) * | 2011-10-12 | 2017-04-13 | Gut Guide Oy | Serotoniinivajeeseen liittyvän terveysriskin arvioiminen |
| WO2016036615A1 (en) | 2014-09-03 | 2016-03-10 | California Institute Of Technology | Microbe-based modulation of serotonin biosynthesis |
| ITUA20164188A1 (it) * | 2016-06-08 | 2017-12-08 | Sofar Spa | Nuovo uso medico di probiotici |
| JP7074133B2 (ja) * | 2016-10-26 | 2022-05-24 | 味の素株式会社 | 目的物質の製造方法 |
| JP2018164453A (ja) * | 2017-03-28 | 2018-10-25 | 株式会社アドバンス | 腸内フローラ用可食性組成物 |
| CN107523526B (zh) | 2017-10-17 | 2020-05-12 | 无限极(中国)有限公司 | 一种罗伊氏乳杆菌及其用途 |
| AU2019216129B2 (en) | 2018-02-02 | 2022-03-17 | Kobiolabs, Inc. | Lactobacillus plantarum KBL396 strain and use thereof |
-
2020
- 2020-11-06 WO PCT/SE2020/051075 patent/WO2021091474A1/en not_active Ceased
- 2020-11-06 JP JP2022526090A patent/JP7649782B2/ja active Active
- 2020-11-06 CN CN202080077257.0A patent/CN114729299B/zh active Active
- 2020-11-06 ES ES20807535T patent/ES2961551T3/es active Active
- 2020-11-06 EP EP23186579.1A patent/EP4253571A3/en active Pending
- 2020-11-06 CA CA3159798A patent/CA3159798A1/en active Pending
- 2020-11-06 PL PL20807535.8T patent/PL3897836T3/pl unknown
- 2020-11-06 BR BR112022008559A patent/BR112022008559A2/pt unknown
- 2020-11-06 MX MX2022005064A patent/MX2022005064A/es unknown
- 2020-11-06 KR KR1020227018293A patent/KR102707788B1/ko active Active
- 2020-11-06 PH PH1/2022/551075A patent/PH12022551075A1/en unknown
- 2020-11-06 IL IL292709A patent/IL292709B2/en unknown
- 2020-11-06 HU HUE20807535A patent/HUE063707T2/hu unknown
- 2020-11-06 MY MYPI2022002296A patent/MY208563A/en unknown
- 2020-11-06 AU AU2020379517A patent/AU2020379517B2/en active Active
- 2020-11-06 EP EP20807535.8A patent/EP3897836B1/en active Active
- 2020-11-06 HR HRP20231084TT patent/HRP20231084T1/hr unknown
- 2020-11-06 US US17/623,543 patent/US12295975B2/en active Active
-
2022
- 2022-04-22 ZA ZA2022/04539A patent/ZA202204539B/en unknown
- 2022-04-25 CL CL2022001042A patent/CL2022001042A1/es unknown
- 2022-04-25 CO CONC2022/0005107A patent/CO2022005107A2/es unknown
- 2022-06-07 EC ECSENADI202245408A patent/ECSP22045408A/es unknown
-
2025
- 2025-02-13 US US19/052,787 patent/US20250222048A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202204539B (en) | 2023-11-29 |
| EP4253571A3 (en) | 2023-12-13 |
| EP3897836A1 (en) | 2021-10-27 |
| CN114729299B (zh) | 2024-06-18 |
| US20220354909A1 (en) | 2022-11-10 |
| US20250222048A1 (en) | 2025-07-10 |
| JP7649782B2 (ja) | 2025-03-21 |
| IL292709B2 (en) | 2024-02-01 |
| AU2020379517B2 (en) | 2024-07-18 |
| CA3159798A1 (en) | 2021-05-14 |
| CN114729299A (zh) | 2022-07-08 |
| KR102707788B1 (ko) | 2024-09-19 |
| AU2020379517A1 (en) | 2022-05-26 |
| EP3897836C0 (en) | 2023-08-16 |
| IL292709B1 (en) | 2023-10-01 |
| BR112022008559A2 (pt) | 2022-08-09 |
| CL2022001042A1 (es) | 2022-11-11 |
| NZ787154A (en) | 2024-11-29 |
| PL3897836T3 (pl) | 2023-10-30 |
| MX2022005064A (es) | 2022-05-18 |
| EP3897836B1 (en) | 2023-08-16 |
| JP2023501358A (ja) | 2023-01-18 |
| IL292709A (en) | 2022-07-01 |
| ES2961551T3 (es) | 2024-03-12 |
| WO2021091474A1 (en) | 2021-05-14 |
| EP4253571A2 (en) | 2023-10-04 |
| MY208563A (en) | 2025-05-15 |
| PH12022551075A1 (en) | 2023-09-18 |
| HRP20231084T1 (hr) | 2023-12-22 |
| CO2022005107A2 (es) | 2022-05-10 |
| KR20220094211A (ko) | 2022-07-05 |
| US12295975B2 (en) | 2025-05-13 |
| HUE063707T2 (hu) | 2024-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP22045408A (es) | Bacterias productoras de serotonina | |
| BR112017001910A2 (pt) | uso de bacillus methylotrophicus como estimulante do crescimento vegetal e meio de controle biológico e cepas isoladas desta espécie | |
| AR079582A1 (es) | Proceso de biodegradacion empleando composicion microbiana | |
| BR112017017805A2 (pt) | composição | |
| AR075165A1 (es) | Cepa de pasteuria | |
| BR112013011263A2 (pt) | "composição nematicida, e método para controlar nematódeos" | |
| EA201891889A1 (ru) | Бактерии lactobacillus fermentum с противогрибковой активностью | |
| EA201270731A8 (ru) | Переработка органических отходов | |
| CY1125009T1 (el) | Προβιοτικα βακτηριδια για ιχθεις | |
| AR100101A1 (es) | Cepas de streptomyces microflavus y métodos de uso de las mismas para controlar enfermedades y plagas en plantas | |
| MX356959B (es) | Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos. | |
| MX2010002867A (es) | Cepas de micoplasma atenuadas vivas. | |
| MX393266B (es) | Composiciónpara usarse en terapia de microbiota | |
| CY1110624T1 (el) | Βακτηριακη καλλιεργεια που εχει αποτελεσματα καταστολης της αναπτυξης δερματιτιδας και επιταχυνσης της ιασης των πληγων του δερματος, και προϊον που την χρησιμοποιει | |
| CL2020001816A1 (es) | Bacterias probióticas para peces. | |
| MX2015017262A (es) | Mezcla bacteriana altamente productora de sideroforos, su proceso de obtención y su uso como agente inhibidor de fitopatogenos. | |
| EA201992374A1 (ru) | Bacillus amyloliquefaciens qv15 - стимулятор вторичного метаболизма для вторичного метаболизма фенольных соединений и ингибирующей способности экстрактов малины и клубники относительно ферментов, связанных с метаболическим синдромом | |
| CO2021016916A2 (es) | Métodos y composiciones para la fermentación bacteriana anaerobia | |
| AR101538A1 (es) | Cepas bacterianas que tienen actividad antimicrobiana y composiciones de biocontrol que las comprenden | |
| RU2392326C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ L-ТРЕОНИНА С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ, ПРИНАДЛЕЖАЩЕЙ К РОДУ Escherichia, В КОТОРОЙ ИНАКТИВИРОВАН ОПЕРОН ycbPONME (ОПЕРОН ssuEADCB) | |
| MX2016011494A (es) | Cepas de lactobacillus de actuacion rapida y su uso para mejorar la estabilidad aerobica del ensilaje. | |
| PL416658A1 (pl) | Pożywka mikrobiologiczna do hodowli szczepów bakterii stosowanych w biopreparatach do dezodoryzacji odchodów drobiu | |
| RU2392327C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ L-ТРЕОНИНА ИЛИ L-АРГИНИНА С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ, ПРИНАДЛЕЖАЩЕЙ К РОДУ Escherichia, В КОТОРОЙ ИНАКТИВИРОВАН ГЕН chaC ИЛИ ОПЕРОН chaBC | |
| Harounabadi et al. | Identification of new Streptomyces griseus strains with potential antimicrobial activity isolated from Caspian Sea | |
| AR127173A2 (es) | Composición agrícola para prevenir o controlar enfermedades de plantas |